|

ATTR Cardiac Amyloidosis in a Selected Population

RECRUITINGSponsored by Helse Møre og Romsdal HF
Actively Recruiting
SponsorHelse Møre og Romsdal HF
Started2024-09-01
Est. completion2034-02-28
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06458374

Summary

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male \> 50 years
* Female \> 60 years
* operated CTS at Ålesund Hospital

Exclusion Criteria:

* not consented
* do not speak Norwegian
* secondary cause of CTS as traumatic or rheumatic
* cannot be followed \> 5 years due to other medical conditions
* Cardiac disease at time of operation for CTS

Conditions5

ATTR Amyloidosis Wild TypeATTR Gene MutationCardiac AmyloidosisCarpal Tunnel SyndromeHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.